Donald P. Tashkin
David Geffen School of Medicine at UCLA
Los Angeles
CA 90095
USA
Name/email consistency: high
- Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. Tashkin, D.P., Doherty, D.E., Kerwin, E., Matiz-Bueno, C.E., Knorr, B., Shekar, T., Gates, D., Staudinger, H. Int. J. Chron. Obstruct. Pulmon. Dis (2012)
- Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. Tashkin, D.P., Doherty, D.E., Kerwin, E., Matiz-Bueno, C.E., Knorr, B., Shekar, T., Banerjee, S., Staudinger, H. Int. J. Chron. Obstruct. Pulmon. Dis (2012)
- Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Tashkin, D.P., Rennard, S., Hays, J.T., Ma, W., Lawrence, D., Lee, T.C. Chest (2011)
- Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. Tashkin, D.P., Varghese, S.T. Pulm. Pharmacol. Ther (2011)
- Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD. Tashkin, D.P. Expert. Rev. Respir. Med (2010)
- Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Tashkin, D.P. Expert. Rev. Respir. Med (2010)
- Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Tashkin, D.P. Curr. Opin. Pulm. Med (2010)
- Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Tashkin, D.P., Celli, B., Kesten, S., Lystig, T., Mehra, S., Decramer, M. Eur. Respir. J. (2010)
- Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Tashkin, D.P., Fabbri, L.M. Respir. Res. (2010)
- Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Tashkin, D.P. Int. J. Chron. Obstruct. Pulmon. Dis (2010)
- Indacaterol maleate for the treatment of chronic obstructive pulmonary disease. Tashkin, D.P. Expert. Opin. Pharmacother (2010)
- Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Tashkin, D., Celli, B., Kesten, S., Lystig, T., Decramer, M. Respir. Med (2010)
- Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. Tashkin, D.P., Pearle, J., Iezzoni, D., Varghese, S.T. COPD (2009)
- Smoking cessation in chronic obstructive pulmonary disease. Tashkin, D.P., Murray, R.P. Respir. Med (2009)
- Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Tashkin, D.P., Hanania, N.A., McGinty, J., Denis-Mize, K., Chaudry, I. Adv. Ther (2009)
- Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Tashkin, D.P., Donohue, J.F., Mahler, D.A., Huang, H., Goodwin, E., Schaefer, K., Hanrahan, J.P., Andrews, W.T. Respir. Med (2009)
- Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?. Tashkin, D.P. CMAJ (2009)
- A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin, D.P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., Decramer, M. N. Engl. J. Med. (2008)
- Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Tashkin, D.P., Littner, M., Andrews, C.P., Tomlinson, L., Rinehart, M., Denis-Mize, K. Respir. Med (2008)
- Bronchodilator responsiveness in patients with COPD. Tashkin, D.P., Celli, B., Decramer, M., Liu, D., Burkhart, D., Cassino, C., Kesten, S. Eur. Respir. J. (2008)
- Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Tashkin, D.P., Rennard, S.I., Martin, P., Ramachandran, S., Martin, U.J., Silkoff, P.E., Goldman, M. Drugs (2008)
- Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. Tashkin, D.P., Klein, G.L., Colman, S.S., Zayed, H., Schonfeld, W.H. Am. J. Med. (2007)
- Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Tashkin, D.P., Elashoff, R., Clements, P.J., Roth, M.D., Furst, D.E., Silver, R.M., Goldin, J., Arriola, E., Strange, C., Bolster, M.B., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M., Khanna, D., Li, N., Li, G. Am. J. Respir. Crit. Care Med. (2007)
- Cyclophosphamide versus placebo in scleroderma lung disease. Tashkin, D.P., Elashoff, R., Clements, P.J., Goldin, J., Roth, M.D., Furst, D.E., Arriola, E., Silver, R., Strange, C., Bolster, M., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D.E., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M. N. Engl. J. Med. (2006)
- The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Tashkin, D.P. Am. J. Med. (2006)
- Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?. Tashkin, D.P. Curr. Opin. Pulm. Med (2005)
- Smoked marijuana as a cause of lung injury. Tashkin, D.P. Monaldi. Arch. Chest. Dis (2005)
- The role of long-acting bronchodilators in the management of stable COPD. Tashkin, D.P., Cooper, C.B. Chest (2004)
- Evidence implicating cocaine as a possible risk factor for HIV infection. Tashkin, D.P. J. Neuroimmunol. (2004)
- Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II. Tashkin, D.P., Murray, H.E., Skeans, M., Murray, R.P. Chest (2004)
- Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Tashkin, D., Kesten, S. Chest (2003)
- Airway effects of marijuana, cocaine, and other inhaled illicit agents. Tashkin, D.P. Curr. Opin. Pulm. Med (2001)
- Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Tashkin, D., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M., Gonzales, D., Dozier, G., Patel, M.K., Jamerson, B. Lancet (2001)
- HFA-BDP and its implications for the quiet zone. Tashkin, D.P. Respir. Med (2000)